Camp4 Therapeutics (CAMP) Interest & Investment Income (2023 - 2026)

Camp4 Therapeutics has reported Interest & Investment Income for 4 years, with the latest figure at $910000.0 in Q1 2026.

• Quarterly Interest & Investment Income rose 54.76% year-over-year to $910000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.5 million (up 63.89% YoY) and the FY2025 annual result came in at $2.2 million, up 63.46% from the prior year.
• Interest & Investment Income rose to $910000.0 in Q1 2026 per CAMP's latest filing, from $710000.0 in the prior quarter.
• Over five years, Interest & Investment Income peaked at $910000.0 in Q1 2026 and troughed at $94000.0 in Q3 2024.
• A 4-year average of $515636.4 and a median of $569000.0 in 2023 frame the typical range for Interest & Investment Income.
• The sharpest annual moves came in 2024 and 2025: Interest & Investment Income plunged 86.36% in 2024, then jumped 350.0% in 2025.
• Over 4 years, Interest & Investment Income stood at $569000.0 in 2023, then grew by 7.21% to $610000.0 in 2024, then increased by 16.39% to $710000.0 in 2025, then advanced by 28.17% to $910000.0 in 2026.
• According to Business Quant data, Interest & Investment Income over the past three periods registered $910000.0, $710000.0, and $423000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.